These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30096310)

  • 1. Microbiome: Focus on Causation and Mechanism.
    Fischbach MA
    Cell; 2018 Aug; 174(4):785-790. PubMed ID: 30096310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond borders: investigating microbiome interactivity and diversity for advanced biocontrol technologies.
    Berg G
    Microb Biotechnol; 2015 Jan; 8(1):5-7. PubMed ID: 25627938
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microbiota and Cancer: a "pas de deux"?].
    Stallmach A; Steube A
    Dtsch Med Wochenschr; 2017 Feb; 142(4):254-260. PubMed ID: 28235225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commensal Koch's postulates: establishing causation in human microbiota research.
    Neville BA; Forster SC; Lawley TD
    Curr Opin Microbiol; 2018 Apr; 42():47-52. PubMed ID: 29112885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age.
    Stearns JC; Davidson CJ; McKeon S; Whelan FJ; Fontes ME; Schryvers AB; Bowdish DM; Kellner JD; Surette MG
    ISME J; 2015 May; 9(5):1246-59. PubMed ID: 25575312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wisconsin microbiome study, a cross-sectional investigation of dietary fibre, microbiome composition and antibiotic-resistant organisms: rationale and methods.
    Eggers S; Malecki KM; Peppard P; Mares J; Shirley D; Shukla SK; Poulsen K; Gangnon R; Duster M; Kates A; Suen G; Sethi AK; Safdar N
    BMJ Open; 2018 Mar; 8(3):e019450. PubMed ID: 29588324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human and Extracellular DNA Depletion for Metagenomic Analysis of Complex Clinical Infection Samples Yields Optimized Viable Microbiome Profiles.
    Nelson MT; Pope CE; Marsh RL; Wolter DJ; Weiss EJ; Hager KR; Vo AT; Brittnacher MJ; Radey MC; Hayden HS; Eng A; Miller SI; Borenstein E; Hoffman LR
    Cell Rep; 2019 Feb; 26(8):2227-2240.e5. PubMed ID: 30784601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplant associated infections-The role of the gastrointestinal microbiota and potential therapeutic options.
    Chan S; Hawley CM; Campbell KL; Morrison M; Campbell SB; Isbel NM; Francis RS; Playford EG; Johnson DW
    Nephrology (Carlton); 2020 Jan; 25(1):5-13. PubMed ID: 31587409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical site infections and the microbiome: An updated perspective.
    Wenzel RP
    Infect Control Hosp Epidemiol; 2019 May; 40(5):590-596. PubMed ID: 30786943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAL Fluid Metaproteome in Acute Respiratory Failure.
    Jagtap PD; Viken KJ; Johnson J; McGowan T; Pendleton KM; Griffin TJ; Hunter RC; Rudney JD; Bhargava M
    Am J Respir Cell Mol Biol; 2018 Nov; 59(5):648-652. PubMed ID: 30382775
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of critical antibiotic resistance genes through routine microbiome surveillance.
    Burcham ZM; Schmidt CJ; Pechal JL; Brooks CP; Rosch JW; Benbow ME; Jordan HR
    PLoS One; 2019; 14(3):e0213280. PubMed ID: 30870464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.
    de Lastours V; Fantin B
    Future Microbiol; 2015; 10(7):1241-55. PubMed ID: 26119580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients.
    Koh AY
    Clin Chem; 2017 Nov; 63(11):1685-1694. PubMed ID: 28720679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in liver disease: better diagnostics are needed.
    Shallcross L; O'Brien A
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):151-153. PubMed ID: 28404125
    [No Abstract]   [Full Text] [Related]  

  • 15. Can molecular DNA-based techniques unravel the truth about diabetic foot infections?
    Malone M; Gosbell IB; Dickson HG; Vickery K; Espedido BA; Jensen SO
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27291330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective of infection and infectious disease.
    Petersen P
    Perspect Biol Med; 1980; 23(2 PT1):255-72. PubMed ID: 6988797
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bacterial infections in newborn infants. Diagnostic criteria, principles of treatment, prevention].
    Aujard Y
    Rev Prat; 1991 Nov; 41(23):2375-9. PubMed ID: 1792508
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanotechnology in the detection and control of microorganisms.
    Luo PG; Stutzenberger FJ
    Adv Appl Microbiol; 2008; 63():145-81. PubMed ID: 18395127
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent Advances and Understanding of Using Probiotic-Based Interventions to Restore Homeostasis of the Microbiome for the Prevention/Therapy of Bacterial Diseases.
    Suchodolski JS; Jergens AE
    Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical Mechanisms of Pathogen Restriction by Intestinal Bacteria.
    Rangan KJ; Hang HC
    Trends Biochem Sci; 2017 Nov; 42(11):887-898. PubMed ID: 28927699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.